Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-866-1 | CAS number: 75-37-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Link to relevant study records
- Endpoint:
- toxicity to reproduction
- Remarks:
- other: dominant lethal assay
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- This study is used for read-across and therefore has been assigned a reliability of 2 (reliable with restrictions). Otherwise the study has a reliability of 1 (reliable without restriction). This study was selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labeling and/or risk assessment.
- Qualifier:
- according to guideline
- Guideline:
- other: Rodent dominant lethal assay, antifertility and germ cell mutation (equivalent or similar to OECD 478)
- Principles of method if other than guideline:
- Rodent dominant lethal study: antifertility and germ cell cell mutation assay.
- GLP compliance:
- yes
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- CD-1 male mice, seven to eight weeks old, were supplied by Charles River UK Ltd, Margate, Kent and housed individually on double-sided mobile mouse racks, each having stainless steel cages of internal measurements: length 28.5 cm, width 11 cm and height 7.5 cm and wire mesh floors. The mice were sequentially numbered by ear punching and were housed in this same order.
Female CD1 mice, eight to nine weeks old, were supplied with the males while further batches of females were supplied at weekly intervals during the experiment. Before mating they were acclimatised to their new environment for 12 days and were housed 10 per cage on rack similar to that described for males with cages of internal measurements: length 27.5 cm, width 25.5 cm, height 10 cm. After mating they were housed 2 per cage and identified with the number of the male with which they were housed during mating.
The environment was maintained at 21 – 25°C with relative humidity at approximately 50%. Alternate 12 hr light and dark cycles were controlled with a timer starting at 6 am. The animals received Alderley Park diet supplied and water (provided by an automatic drinker system) ad libitum except for the males during the exposure period. - Route of administration:
- inhalation
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- The HFC 134a treated animals were exposed by inhalation each day for six hours per day on five consecutive days. The negative and positive controls were similarly housed in exposure chambers receiving air. During exposure animals were housed individually without access to food or water in one of twenty compartments in a box made of steel and glass with an internal capacity of approximated 3 litres. Atmospheres of HFC 134a were generated by mixing volumes of the test compounds with air and using rotameters as initial indicators of concentration. The concentrations were monitored by a gas-liquid chromatograph (GLC). The animals of the two positive control groups were maintained in a similar air flow to the negative control animals but were dosed prior to being housed in the exposure boxes. They received either five daily oral doses of ethyl methanesulphonate (EMS) in distilled water or a single intraperitoneal injection of cyclophosphamide in 0.9% saline.
- Details on mating procedure:
- During exposure animals were housed individually without access to food or water in one of twenty compartments in a box made of steel and glass with an internal capacity of approximated 3 litres. Test substance atmospheres were generated by mixing volumes of the test compound with air and using rotameters as initial indicators of concentration. The concentrations were monitored by a gas-liquid chromatograph (GLC). The animals of the two positive control groups were maintained in a similar air flow to the negative control animals but were dosed prior to being housed in the exposure boxes. They received either five daily oral doses of ethyl methanesulphonate (EMS) in distilled water or a single intraperitoneal injection of cyclophosphamide in 0.9% saline.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Atmospheric concentrations in the exposure chambers were monitored by gas-liquid chromatography and mean atmospheric concentrations calculated
- Duration of treatment / exposure:
- 5 days
- Frequency of treatment:
- 6 hours/day
- Remarks:
- Doses / Concentrations:
0, 1000, 10000, 50000 ppm
Basis:
nominal conc. - Remarks:
- Doses / Concentrations:
0, 900, 10200, 50700 ppm
Basis:
analytical conc. - No. of animals per sex per dose:
- 30 males for mating from negative control
15 males for mating from test substance and positive controls - Control animals:
- yes, sham-exposed
- Details on study design:
- After an acclimatisation period of 12 days, a pre-experimental fertility test was carried out on the males. Two females were housed with each male, left for four nights, then re-housed. It was assumed that most matings would take place soon after pairing. The females were therefore not examined for vaginal plugs, but were killed (by cervical dislocation) 15 days after first introducing them to the males. Their uteri were examined for live implantations, early deaths and late deaths. The animals were graded according to fertility and extent of background dominant lethal frequency, choosing where possible those successful in fertilising both females but excluding those with a high dominant lethal frequency. The selected males were randomly allocated to six experimental groups. Following the allocation process the males remained housed sequentially on the racks so the groups to which they were allocated were therefore randomly distributed. The experimental outline and groups sizes are shown in Table 1, excess animals being included at this stage to allow for deaths or ill resulting from dosing.
- Positive control:
- 5 oral doses of ethyl methane sulphonate (EMS) or a single i.p. dose of cyclophosphamide (CTX)
- Parental animals: Observations and examinations:
- All animals were checked daily throughout the study, the males being checked twice daily during exposure. All abnormal observations were recorded.
- Postmortem examinations (parental animals):
- Deaths were recorded, but the animals were not given a post-mortem examination.
- Statistics:
- Data from the test substance exposed groups and positive control groups were compared statistically with those from the negative control groups.
To assess fertility, two methods were used:
i) the percentage of pregnant females was analysed using the Chi-squared test
ii) the number of successful matings per male was analysed using Student’s t-test
Pre-implantation egg losses, whilst representing some of the mutagenic effect, are not as important as the post-implantational losses since such losses could be due to other than genetic factors. Pre-implantation egg loss in the present study has thus been measured by comparing values of total implantations in females mated with treated males and control males instead of counting corpora lutea. The total number of implantations per pregnancy was considered by analysis of variance and group means were compared using a one-sided Student’s t-test based on this analysis. - Reproductive indices:
- The number of early deaths, late deaths and live implantations observed during the uterine examination were recorded and the resultant data processed and analysed statistically.
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- not examined
- Food consumption and compound intake (if feeding study):
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Other effects:
- not examined
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Dose descriptor:
- NOEC
- Effect level:
- 50 000 ppm
- Sex:
- male
- Basis for effect level:
- other: No effects on reproductive performance of male mice at highest concentration tested.
- Clinical signs:
- not examined
- Mortality / viability:
- not examined
- Body weight and weight changes:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings:
- not examined
- Dose descriptor:
- NOEC
- Generation:
- F1
- Effect level:
- 50 000 ppm
- Sex:
- male/female
- Basis for effect level:
- mortality
- Reproductive effects observed:
- not specified
- Conclusions:
- HFC 134a did not affect male fertility or cause mutagenic effects through sperm.
- Executive summary:
In a dominant lethal assay, CD1 male mice were exposed to 0, 1000, 10000 or 50000 ppm test substance 6 hours a day for 5 days. Positive control groups received either 5 daily oral doses of ethyl methanesulphonate or a single intraperitoneal dose of cyclophosphamide. After the last exposure, each male was housed with 2 virgin females for 4 consecutive nights. Further matings with new females were conducted at weekly intervals for a total of 8 times.
Despite occasional statistical differences between the test substance and the negative control groups, this study indicated that the test substance does not did not affect male fertility or cause mutagenic effects through sperm. This lack of effect was not due to a lack of sensitivity of the test system since the expected positive responses were demonstrated by ethyl mehtanesulphonate and cyclophosphamide. The NOAEC for this study was >50000 ppm.
Reference
Table 2: Daily atmospheric concentrations (%v/v) - standard deviations are in parenthesis |
|||
Day |
Test substance |
||
1000 ppm (0.1% v/v) |
10 000 ppm (1.0% v/v) |
50 000 ppm (5.0% v/v) |
|
1 |
0.07 (0.03) |
1.10 (0.23) |
5.24 (0.60) |
2 |
0.08 (0.01) |
1.05 (0.25) |
5.41 (0.51) |
3 |
0.07 (0.06) |
0.98 (0.12) |
4.74 (0.21) |
4 |
0.10 (0.01) |
0.96 (0.08) |
5.00 (0.14) |
5 |
0.12 (0.09) |
0.99 (0.12) |
4.97 (0.73) |
Mean |
0.09 (0.02) |
1.02 (0.06) |
5.07 (0.26) |
Fertility (Tables 3 and 4):
Percentage of Females pregnant (Table 3): The only significant effect in the test substance treated groups occurred in week 7 where there was a reduction in pregnancy in the low dose group. The positive control groups had significantly lower percentages in weeks 1, 2, 7, and 8 for EMS and weeks 1, 3, 4, 6, and 7 for CTX.
Table 3: Percentage of mated female mice that became pregnant |
||||||
Test substance |
EMS |
CTX |
||||
Weeks |
Control |
1000 ppm |
10 000 ppm |
50 000 ppm |
150 mg/kg orally |
200 mg/kg i.p. |
Before treatment |
98.3 (60) |
96.7 (30) |
100 (30) |
100 (30) |
100 (30) |
96.7 (30) |
1 |
90.0 (60) |
93.3 (30) |
90.0 (30) |
83.3 (30) |
60.0 ** (30) |
70.0* (30) |
2 |
93.3 (60) |
80.0 (30) |
96.7 (30) |
90.0 (30) |
66.7* (30) |
83.3 (30) |
3 |
95.0 (60) |
93.3 (30) |
93.3 (30) |
90.0 (30) |
100 (30) |
76.7* (30) |
4 |
96.7 (60) |
93.3 (30) |
100 (30) |
93.3 (30) |
93.3 (30) |
76.7* (30) |
5 |
95.0 (60) |
86.7 (30) |
93.3 (30) |
93.3 (30) |
90.0 (30) |
92.9 (28) |
6 |
91.7 (60) |
90.0 (30) |
96.6 (29) |
90.0 (30) |
100 (30) |
57.7*** (26) |
7 |
100 (60) |
83.3** (30) |
96.7 (30) |
93.3 (30) |
90.0* (30) |
70.0*** (20) |
8 |
98.3 (60) |
100 (26) |
96.7 (30) |
96.7 (30) |
83.3* (30) |
57.1*** (14) |
The number in brackets is the total number of females mated in the experiment at a given time. Statistically significant differences compared to control: *5%, **1%,***0.1% level based on the χ2 test. |
Successful mating per male (Table 4): Both the low and high dose test substance groups had reduced mean numbers of successful matings per male in week 7. The value for the middle dose group was slightly lower than for control and the pooled group value was also significantly lower. The analysis of the two positive control groups gave the same significant values as those described for the percentages of females pregnant.
Table 4: Frequency distribution (and mean number†) of successful matings per male mouse |
|||||||
Test substance |
EMS |
CTX |
|||||
Weeks |
Number of successful matings |
Control |
1000 ppm |
10 000 ppm |
50 000 ppm |
150 mg/kg orally |
200 mg/kg i.p. |
Before treatment |
0 1 2 |
0 1 29 (100%) |
0 1 14 (100%) |
0 0 15 (100%) |
0 0 15 (100%) |
0 0 15 (100%) |
0 1 14 (100%) |
1 |
0 1 2 |
1 4 25 (96.7%) |
0 2 13 (100%) |
0 3 12 (100%) |
0 5 10 (100%) |
1*** 10 4 (93.3%) |
1* 7 7 (93.3%) |
2 |
0 1 2 |
0 4 26 (100%) |
2 2 11 (86.7%) |
0 1 14 (100%) |
0 3 12 (100%) |
2** 6 7 (86.7%) |
1 3 11 (93.3%) |
3 |
0 1 2 |
0 3 27 (100%) |
0 2 13 (100%) |
0 2 13 (100%) |
0 3 12 (100%) |
0 0 15 (100%) |
2* 3 10 (86.7%) |
4 |
0 1 2 |
0 2 28 (100%) |
1 0 14 (93.3%) |
0 0 15 (100%) |
0 2 13 (100%) |
0 2 13 (100%) |
2** 3 10 (86.7%) |
5 |
0 1 2 |
0 3 27 (100%) |
1 2 12 (93.3%) |
0 2 13 (100%) |
0 2 13 (100%) |
0 3 12 (100%) |
1 0 13 (92.9%) |
6 |
0 1 2 |
0 5 25 (100%) |
1 1 13 (93.3%) |
0 1 13 (100%) |
1 1 13 (93.3%) |
0 0 15 (100%) |
5** 1 7 (61.6%) |
7 |
0 1 2 |
0 0 30 (100%) |
1** 3 11 (93.3%) |
0 1 14 (100%) |
0* 2 13 (100%) |
0** 3 12 (100%) |
2*** 2 6 (80.0%) |
8 |
0 1 2 |
0 1 29 (100%) |
0 0 13 (100%) |
0 1 14 (100%) |
0 1 14 (100%) |
0** 5 10 (100%) |
3*** 0 4 57.1% |
Statistically significant differences compared to control: *5%, **1%, ***0.1% level based on Student’s t-test of mean number of successful matings. †Only males paired with two live healthy females have been included |
In week 7, the significant decrease in the number of males mating with both females in the 1000 ppm test substance group can be explained by two factors: unusually high control values (100% of males mated with both females) and by two males which mated with only one or neither of the two females because of health reasons. One of these males was found to have an abscess on the penis and, retrospectively, it can be seen that from week 4 of mating (abscess first detected week 5) until week 7 when it was killed, the animal failed to mate with any of the females with which it was paired. After both animals had been killed in week 7, 100% of the males in this group mated with both females the following week. It should also be stressed that despite any statistical differences, the fertility in the test substance treated groups remained high throughout the experiment, while the two positive control groups showed definite fertility effects due to treatment in the early weeks of the experiment. The significant effects in the EMS group in weeks 7 and 8 were again probably influenced by the negative control values while those for weeks 6, 7, and 8 in the CTX group were probably an indirect effect caused by the delayed toxicity of CTX since several males died during this time and presumably did not mate before they died.
Implantations: Analysis of the numbers of implantations per pregnancy revealed no significant effects in the test substance groups. Both positive controls EMS and CTX produced very significantly reduced mean numbers of implantations per pregnancy in weeks 1 and 2. The effect of CTX was also apparent in weeks 3 and 6.
Early Deaths: Early deaths which are the most sensitive indicator or mutagenicity in the dominant lethal test were statistically significantly increased in the group of male mice exposed to the top dose of the test substance in weeks 4 and 8, while in week 7 the pooled value for all three test substance treated groups was significantly higher than that of the negative control. The actual increases, especially when compared to the positive control values in weeks 1 and 2 were very small. On examination of the negative control data, it was seen that at weeks 4, 7 and 8 the numbers of early deaths were particularly low. Furthermore except when the percentage of pregnant females with at least one early death was considered, the values found to be statistically significant for the test substance treated groups fell within the range obtained for the negative control group. That these effects were due to low negative control values was also borne out by the statistically significant increases in the positive control groups in weeks 4, 7, and 8 which have not been seen in previous studies which showed a good degree of correlation. A subsequent experiment using cyclophosphamide (CTX) did, however, show a slight increase in week 4. There was no effect on the number of implantations in the test substance treated groups and it is usual for pre- and post-implantation loss to be associated with a mutagenic effect, as was demonstrated by the positive controls.
Late deaths: The proportion of females with late deaths showed a significant increase in the 10000 ppm test substance group. Since this was an isolated finding which did not show a dose response it was unlikely to have been treatment related and was slightly greater than a value observed before treatment in one of the groups.
Conclusion: The test substance had no effect on fertility and is unlikely to cause mutagenic effects as assessed by the mouse dominant lethal assay.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 210 000 mg/m³
- Species:
- rat
Additional information
No reproductive toxicity data are available for the test substance. Dominant lethal and fertility data with 1,1,1,2-tetrafluoroethane (HFC 134a) were used as a read-across to fulfill the data gap for the test substance. The underlying hypothesis for the read-across between the test substance and HFC 134a is that the substances are structurally similar and possess similar physicochemical properties that account for their poor absorption in the body, neither has significant acute or subchronic toxicity (including histopathological effect on reproductive organs) event at the highest concentrations tested, and are not classified as hazardous to health. Additional documentation, provided within the IUCLID Assessment Reports section, supports the read-across approach.
In a dominant lethal assay, CD1 male mice were exposed to 0, 1000, 10000 or 50000 ppm1,1,2 -tetrafluoroethane (HFC 134a) for 6 hours a day for 5 days. This study indicated that the test substance does not did not affect male fertility or cause mutagenic effects through sperm. The NOAEC for this study was >50000 ppm.
1,1,2 -tetrafluoroethane (HFC 134a) was administered to AHA rats by snout only inhalation to assess the effects on reproduction and development. In the fertility element of the study, rats were exposed to atmospheres of 2500, 10000 or 50000 ppm HFC 134a for 1 hour/day throughout gametogenesis, mating, pregnancy and lactation. The only treatment related effect was a slight reduction in body weight gain of the treated parental generation at 50000 ppm (208000 mg/m3). There were no adverse effects of HFC 134a on the fertility and reproductive performance of treated animals or on the development, maturation or reproductive performance of up to two successive generations. The NOAEL for the P, F1,and F2 generations was ≥50000 ppm.
Additionally, male and female rats were exposed to the test substance at 0, 0.2, 1, or 2.5% v/v via inhalation for 24 months. No survival or life-shortening effects were observed at any exposure concentration. No histopathological or weight changes were observed in reproductive organs at any concentration tested. Based on this information, the NOAEC was 2.5% (67485 mg/m3).
Overall, the reproductive data from the read-across chemical, data from the 2-year inhalation study with the test substance, the poor absorption, and lack or reactivity and rapid elimination of unmetabolised test substance suggest that test substance-related reproductive toxicity via inhalation is unlikely.
Short description of key information:
NOAEC = 210000 mg/m3
Justification for selection of Effect on fertility via inhalation route:
Equivalent to OECD 478, Reliability = 2
Effects on developmental toxicity
Description of key information
NOAEC = 135000 mg/m3
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: This study was selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labelling and/or risk assessment.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- yes
- Remarks:
- Only 2 concentrations tested; dosing through day 15G (not through to the day prior to scheduled sacrifice); no food consumption data collected; no data on gravid uterus weight.
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Charles River-CD®
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: Not reported
- Weight at study initiation: Approximately 185 g
- Fasting period before study: No
- Housing: Individually in suspended stainless steel wire-mesh cages
- Diet (e.g. ad libitum): ad libitum, except during exposures
- Water (e.g. ad libitum): ad libitum, except during exposures
- Acclimation period: Not reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.4-23.3°C
- Humidity (%): 50%
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): Not reported - Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- other: Air
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 1.4 cubic meter stainless steel and glass chambers
- Method of holding animals in test chamber: Not reported
- Source and rate of air: Not reported
- Method of conditioning air: Not reported
- System of generating particulates/aerosols: The desired concentrations were generated by metering vapours of the test substance from the cylinder into 1.4 cubic meter stainless steel and glass chambers operating under dynamic airflow conditions. The control animals were exposed to room air in identical chambers.
- Temperature, humidity, pressure in air chamber: Not reported
- Air flow rate: Not reported
- Air change rate: Not reported
- Treatment of exhaust air: Not reported
TEST ATMOSPHERE
- Brief description of analytical method used: Chamber atmospheres were monitored every 30 minutes using Teflon® lines connected to a gas chromatograph fitted with a sample loop injection and stream selection valve. The GC was calibrated daily with gaseous standards.
- Samples taken from breathing zone: yes - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Chamber atmospheres were monitored every 30 minutes via gas chromatograph (GC). The GC was calibrated daily with gaseous standards. The daily average analytical exposure levels during the entire 10-day exposure period were 5300 ± 1200 and 45300 ± 4900 ppm.
- Details on mating procedure:
- - Impregnation procedure: purchased timed pregnant; the morning when sperm were found in the vaginal smear was counted as Day 1 of gestation. One-half of the females were bred on Day 0 and the other half on Day 0 + 2. All females were received in one shipment as 4 and 2 days pregnant.
- Duration of treatment / exposure:
- 6 hours/day
- Frequency of treatment:
- Days 6 - 15 of gestation
- No. of animals per sex per dose:
- 27 female rats per dose
- Control animals:
- yes, concurrent vehicle
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Daily
BODY WEIGHT: Yes
- Time schedule for examinations: On day of receipt, when first exposed, twice weekly during exposure, and day of sacrifice
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): No
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 21
- Organs examined: Ovaries, uterine horns, vital organs and tissues - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - Foetal Weight and crown-rump length of all live foetuses
- External examinations: Yes: [all per litter]
- Soft tissue examinations: Yes: [half per litter]
- Skeletal examinations: Yes: [half per litter]
- Head examinations: Yes: [half per litter] - Statistics:
- For statistical evaluation of the data, the litter was considered the experimental unit of treatment and observation. The Fisher Exact probability test was used to evaluate the incidence of resorptions and abnormalities among litters. Maternal and foetal body weights and foetal crown-rump measurements were treated statistically by analysis of variance and least significant difference (LSD) tests. The number of corpora lutea, implantations, and live foetuses per litter were analyzed by the Wilcoxon rank sum test. In all cases, two-tailed significance tests were performed and significance was judged at the 0.05 probability level.
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
- Dose descriptor:
- NOAEC
- Effect level:
- 50 000 ppm (nominal)
- Basis for effect level:
- other: maternal toxicity
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
Petechial haemorrhages and small subcutaneous hematomas on various parts of the body and the number of runts among litters and foetuses were similar in all groups. Apparent hydronephrosis, transposition of the viscera, liver peliosis, and internal haemorrhage were detected; however, none of these findings were considered to be treatment-related. - Dose descriptor:
- NOAEC
- Effect level:
- 50 000 ppm (nominal)
- Basis for effect level:
- other: teratogenicity
- Abnormalities:
- not specified
- Developmental effects observed:
- not specified
- Conclusions:
- The study and the conclusions which are drawn from it fulfil the quality criteria (validity, reliability, repeatability). The NOEC for maternal and developmental toxicity was 50000 ppm, the highest level tested.
- Executive summary:
Pregnant rats were exposed to nominal concentrations of 0, 5000, and 50000 ppm of the test substance for 6 hours per day on Days 6 through 15 of gestation. The animals were observed daily for signs of toxicity and changes in demeanour and behaviour. They were weighed on days they were received, when first exposed, twice weekly during the exposure and on the day of sacrifice.
Inhalation exposure did not produce clinical signs of toxicity or changes in behaviour in pregnant rats exposed for 6 hours daily on Days 6 through 15 of gestation. The outcome of pregnancy measured by the number of corpora lutea, implantation sites, resorptions, and live foetuses per litter, was not adversely affected by the treatment. The exposures did not affect embryonal development as measured by weight, crown-rump length, and gross external, visceral, and skeletal examination of the foetuses. Under the conditions of this study, the test substance was not embryotoxic or teratogenic in rats. The NOEC for maternal and developmental toxicity was 50000 ppm, the highest dose tested.
Reference
A summary of other reproductive outcomes (means/litter) are provided in the table below:
Concentration (ppm) |
0 |
5000 |
50000 |
Corpora lutea: |
11.6 |
11.3 |
12.2 |
Implantations: |
10 |
9.4 |
10.5 |
No. of Resorptions: |
1.5 |
1.4 |
1.2 |
Total No. of Foetuses: |
9.3 |
8.8 |
9.9 |
Total No. of Live Foetuses: |
9.3 |
8.8 |
9.9 |
Mean Foetal Weight (g): |
4.3 |
4.4 |
4.3 |
Sex Ratio: |
NR |
NR |
NR |
NR = Foetal sex was not recorded; therefore, sex ratios could not be calculated. |
A summary of gross, soft tissue, and skeletal anomalies are provided in the table below. Data are presented as number of litters (foetuses) affected:
Concentration (ppm) |
0 |
5,000 |
50,000 |
Gross External, Number examined: |
22(205) |
20(184) |
19(188) |
Petechial haemorrhages |
4(4) |
5(5) |
3(5) |
Hematoma |
10(12) |
6(7) |
8(14) |
Runts |
2(2) |
1(1) |
1(1) |
Soft Tissue, Number examined: |
22(105) |
20(93) |
19(90) |
Hydronephrosis (apparent) |
1(1) |
3(4) |
2(2) |
Situs inversus |
0 |
0 |
1(1) |
Liver peliosis |
0 |
0 |
3(3) |
Internal haemorrhage |
1(1) |
0 |
0 |
Skeletal, Number examined: |
22(100) |
20(91) |
19(98) |
14th rudimentary rib |
16(51) |
16(53) |
19(69) |
Wavy ribs |
8(17) |
6(8) |
5(7) |
Sternebrae unossified |
10(14) |
9(16) |
12(23) |
Bipartite centra |
3(3) |
0 |
2(2) |
Hyoid unossified |
2(3) |
0 |
4(6) |
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 135 000 mg/m³
- Study duration:
- subacute
- Species:
- rat
Additional information
Rats were evaluated in a developmental toxicity via inhalation concentrations up to and including 50000 ppm. No maternal or developmental toxicity was observed at the highest concentration tested, therefore, the NOAEC was 50000 ppm (135000 mg/m3).
Although developmental toxicity studies in rats are available, no developmental toxicity studies in rabbits are available for the test substance. Developmental toxicity studies in rabbits with 1,1,1,2-tetrafluoroethane (HFC 134a), 1,1,1-trifluoroethane (HFC-143a), and 1,1,1,2,2-pentafluoroethane (HFC-125) were used as a read-across to fulfill the data gap for the test substance. The underlying hypothesis for the read-across between the test substance and the read across substances is that the substances are structurally similar and possess similar physicochemical properties that account for their poor absorption in the body, all have no significant acute or subchronic toxicity (including histopathological effect on reproductive organs) event at the highest concentrations tested, and none are classified as hazardous to health. Additional documentation, provided within the IUCLID Assessment Reports section, supports the read-across approach.
A developmental toxicity study with 1,1,1,2 -tetrafluoroethane (HFC 134a) was conducted. HFC-134a was administered via inhalation to groups of female rabbits on days 7-19 of gestation at exposure levels of 0, 2500, 10000 and 40000 ppm. Exposure to concentrations of ≥10000 ppm was associated with slight maternal toxicity manifest as reduced body weight gain and food consumption. There was no evidence of maternal toxicity at 2500 ppm. There was no evidence of embryotoxicity, teratogenicity or foetotoxicity at any exposure level. The NOEC was 2500 ppm (10500 mg/m3) for maternal toxicity and 40000 ppm (168000 mg/m3) for embryotoxicity and fetotoxicity.
A developmental toxicity study with 1,1,1-trifluoroethane (HFC-143a) was conducted. HFC-143a was administered via inhalation to groups of female rabbits on days 6 -18 of gestation at exposure levels of 0, 2000, 10000, and 40000 ppm. There was no evidence of maternal or developmental toxicity at any level tested. The NOEC was greater than 40000 ppm (136000 mg/m3) for the dam and conceptus.
A developmental toxicity study with pentafluoroethane (HFC-125) was conducted. HFC-125 was administered via inhalation to groups of female rabbits on days 6 -18 of gestation at exposure levels of 0, 5000, 15000, and 50000 ppm. There was no evidence of maternal or developmental toxicity at any level tested. The NOEC was greater than 50000 ppm (245000 mg/m3) for the dam and conceptus.
Justification for selection of Effect on developmental toxicity: via inhalation route:
Equivalent to OECD 414, rat, Reliability = 2
Justification for classification or non-classification
The test substance did not adversely affect reproductive organs and was not uniquely toxic to the developing foetus. Additional developmental and reproductive data from read-across substances support the conclusion that the test substance is not expected to be a developmental or reproductive toxin. Therefore, the substance does not need to be classified for reproductive toxicity according the EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.